Central pain in cancer patients Journal Article


Authors: Gonzales, G. R.; Tuttle, S. L.; Thaler, H. T.; Manfredi, P. L.
Article Title: Central pain in cancer patients
Abstract: The prevalence of pain caused by injury to the central nervous system (CNS), or central pain (CP), in cancer patients is unknown. In order to define prevalence and characteristics of central pain in hospitalized patients with cancer, we performed a retrospective review of medical records of patients evaluated by 2 different services: the Pain Service and the Neurology Service, at Memorial Sloan-Kettering Cancer Center. The prevalence of CP in these patients was 4% and 2%, respectively. Primary and metastatic tumors and their therapy, including surgery, radiation and chemotherapy, were all potential causes of CP. The occurrence of CP in patients with primary CNS tumors was higher in patients with spinal cord tumors compared to patients with brain tumors (P < .0001). © 2003 by the American Pain Society.
Keywords: adult; cancer chemotherapy; aged; middle aged; cancer surgery; retrospective studies; major clinical study; united states; cancer radiotherapy; brain tumor; antineoplastic agent; neoplasms; metastasis; pain; haloperidol; lorazepam; opiate; prevalence; risk factors; steroid; cancer pain; retrospective study; risk factor; central nervous system tumor; central nervous system; hospitalization; paracetamol; naproxen; nonsteroid antiinflammatory agent; spinal cord tumor; antidepressant agent; tamoxifen; referral and consultation; morphine; lidocaine; clonazepam; levomepromazine; phenytoin; neurology; carbamazepine; gabapentin; nerve block; central nervous system disease; pamidronic acid; clonidine; spinal cord surgery; amitriptyline; trazodone; anesthetic agent; desipramine; nortriptyline; diazepam; imipramine; pain clinics; baclofen; acetazolamide; cancer; humans; human; male; female; article; transcutaneous nerve stimulation; sumatriptan; central pain; neuropathic
Journal Title: Journal of Pain
Volume: 4
Issue: 6
ISSN: 1526-5900
Publisher: Churchill Livingstone  
Date Published: 2003-08-01
Start Page: 351
End Page: 354
Language: English
DOI: 10.1016/s1526-5900(03)00639-4
PUBMED: 14622693
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 12 September 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Howard T Thaler
    245 Thaler